Clinical Trial Update: Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder [Phase 3]

View source ↗

Summary

This document reports an update on a Phase 3 safety and tolerability study of depot buprenorphine in individuals seeking treatment for opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid-related Disorders

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder, Opioid-related Disorders | Phase 3 | Status: COMPLETED | Results posted: 2018-03-29